BCBA/NVOD (BCBA/NVOD)

Buenos Aires Stock Exchange: BCBA/NVOD · USD

$5.84

-0.10 (-1.7%)· Recorded snapshot

Market cap	263.2T
Revenue (ttm)	74.6T
Net income (ttm)	26.4T
EPS (ttm)	$858
P/E (trailing)	10.5x
P/E (forward)	11.7x
Dividend	$78.3 (0.87%)
Volume	35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 74.6T
Net income (ttm): 26.4T
EPS (ttm): $858
P/E (trailing): 10.5x
P/E (forward): 11.7x
Market cap: 263.2T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.7

P25 n/aP50 n/aP75 n/a

Trailing P/E10.5

P25 n/aP50 n/aP75 n/a

ROE59.8

P25 n/aP50 n/aP75 n/a

ROIC39.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/NVOD indicators

Market & fundamental data

Available fields

220

Groups with data

Currency

DKK

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Denmark
Country code	AR
Earnings date	2026-11-04
Employees	66,700
Employees change	-11,687
Employees growth	-14.91%
Enterprise value	$285T
Exchange	Buenos Aires Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-07-19
Fiscal year end	December
Founded	1923
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	AR0229808610
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	$263.2T
Next earnings date	2026-11-04
Price	$5.84
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/NVOD
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.52x
Average P/E ratio (3Y)	26.67x
Average P/E ratio (5Y)	30.16x
Earnings yield	9.55%
EV/Earnings	10.81x
EV/EBIT	7.7x
EV/EBITDA	7.09x
EV/FCF	16.6x
EV/Sales	3.77x
FCF / EV yield	6.02%
FCF yield	6.52%
Forward P/E	11.69x
Graham number	3.82483
Graham upside	-34.51%
Lynch fair value	$12.45
Lynch upside	113.23%
P/(FCF - SBC) ratio	15.63x
P/(OCF - SBC) ratio	8.91x
P/B ratio	5.25x
P/E ratio	10.47x
P/FCF ratio	15.33x
P/OCF ratio	8.82x
P/S ratio	3.53x
Price / tangible book value	11.72x
Price/EBITDA ratio	6.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	48.99%
EBITDA margin	52.72%
Effective tax rate	21.72%
FCF margin	22.74%
Gross margin	81.99%
Operating margin	48.99%
Pretax margin	45.15%
Profit margin	35.35%
Profit per employee	$395.2M
Profitable quarters	164
Profitable years	41
Revenue per employee	$1.1B
ROA	18.73%
ROA (5Y)	21.35%
ROCE	45.35%
ROE	59.82%
ROE (5Y)	74.56%
ROIC	39.22%
ROIC (5Y)	68.16%
SBC / revenue	0.44%
Tax / revenue	9.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.98%
EPS growth (Q)	-20.61%
EPS growth (QoQ)	-56.63%
EPS growth 10Y	14.01%
EPS growth 3Y	20.74%
EPS growth 5Y	22.33%
EPS growth years	31
FCF growth	14.3%
FCF growth (Q)	56.84%
FCF growth (QoQ)	232.92%
FCF growth 3Y	2.24%
FCF growth 5Y	9.51%
Gross profit growth	2.76%
Gross profit growth (Q)	-4.1%
Gross profit growth 3Y	16.73%
Gross profit growth 5Y	20.17%
Net income growth	4.84%
Net income growth (Q)	-20.81%
Net income growth (QoQ)	-56.77%
Net income growth 3Y	20.09%
Net income growth 5Y	21.29%
Net income growth years	38
OCF growth	7.52%
OCF growth (Q)	32.14%
OCF growth (QoQ)	129.19%
OCF growth 10Y	11.56%
OCF growth 3Y	13.7%
OCF growth 5Y	19.47%
Operating income growth	9.29%
Operating income growth (Q)	-0.18%
Operating income growth 3Y	22.91%
Operating income growth 5Y	24.43%
Revenue growth	5.61%
Revenue growth (Q)	2.12%
Revenue growth (QoQ)	-18.94%
Revenue growth 10Y	11.56%
Revenue growth 3Y	17.84%
Revenue growth 5Y	20.45%
Revenue growth quarters	2
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-12.7T
Depreciation and amortization	$2.8T
EBIT	$36.5T
EBITDA	$39.3T
EPS	$857.69
Financing cash flow	$-5T
Free cash flow	$17.2T
Free cash flow minus SBC	$16.8T
Gross profit	$61.1T
Income taxes	$7.3T
Investing cash flow	$-18.9T
Net borrowing	$8.4T
Net cash flow	$5.9T
Net income	$26.4T
Operating cash flow minus SBC	$29.5T
Operating income	$36.5T
Revenue	$74.6T
Stock-based compensation	$324.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.21
Book value per share	$11,313.07
Debt / EBITDA	0.8
Debt / equity	0.63
Debt / FCF	1.85
Goodwill	$4.6T
Interest coverage	1,566.84
Long-term assets	$86.9T
Long-term liabilities	$29.8T
Net cash (debt)	$-21.5T
Net cash / market cap	-8.18%
Net debt / EBITDA	0.55
Net debt / equity	0.43
Net debt / FCF	1.25
Piotroski F-Score	5
Property, plant and equipment	$53.1T
Shareholders' equity	$50.1T
Tangible book value	$22.5T
Tangible book value per share	$5,072.75
Total assets	$134.7T
Total cash	$10.2T
Total debt	$31.7T
Total liabilities	$84.6T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	$47.8T
Current liabilities	$54.8T
Current ratio	0.87
Inventory turnover	1.22
Net working capital	$-12.9T
Quick ratio	0.64
Working capital	$-6.9T
Working capital turnover	-1,983.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-08-25
Dividend payment years	1
Dividend per share	$78.29
Dividend yield	0.87%
Ex-dividend date	2026-08-14
Last dividend	$0.05
Payout ratio	44.64%
Shareholder yield	1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-1.68%
1M price change	0.52%
1M total return	0.52%
1W price change	-0.34%
1W total return	-0.34%
20-day SMA	$5.81
3M price change	-20.33%
3M total return	-19.36%
50-day SMA	$6.29
52-week high	$7.83
52-week high date	2026-07-03
52-week low	$5.50
52-week low date	2026-10-05
All-time high	$7.83
All-time high date	2026-07-03
All-time low	$5.50
All-time low date	2026-10-05
Average true range (ATR)	$0.15
Average volume	742.8
Change from 52-week high	-25.42%
Change from 52-week low	6.18%
Change from all-time high	-25.42%
Change from all-time low	6.18%
Change from open	-2.01%
Day's gap	0.34%
Dollar volume	$204
High price	$5.98
Low price	$5.83
Monthly RSI	0
Open price	$5.96
Position in 52-week range	6.67%
Previous close	$5.94
Price vs 20-day SMA	0.55%
Price vs 50-day SMA	-7.1%
Relative volume	0.05
RSI	43.77
Sharpe ratio	-0.41
Sortino ratio	-0.45
Volume	35
Weekly RSI	44.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.14%
Shares held by insiders	0.02%
Shares held by institutions	27.52%

Deeper analysis on BCBA/NVOD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/NVOD report

Is a complete BCBA/NVOD research report available?

No complete published report is available for bcba/NVOD (BCBA/NVOD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/NVOD (BCBA/NVOD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NVOD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NVOD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NVOD

Frequently asked questions